Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy
Melinda Magyari(University of Copenhagen), Thor Ameri Chalmer(Rigshospitalet), Bjarne Laursen(University of Southern Denmark), Tomáš Kalinčík(The Royal Melbourne Hospital), Per Soelberg Sørensen(University of Copenhagen)
Cited by 29
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706